Association between hsCRP≥2, Coronary Artery Calcium, and Cardiovascular Events – Implications for the JUPITER Population: Multi-Ethnic Study of Atherosclerosis (MESA)

BACKGROUND: The JUPITER trial demonstrated that some patients with LDL-C <130 mg/dL and hsCRP ≥2 mg/L benefit from rosuvastatin, although absolute event rates were low. We sought to determine whether coronary artery calcium (CAC) may further risk stratify a JUPITER-eligible population, and to com...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Blaha, Michael J., Budoff, Matthew J., DeFilippis, Andrew P., Blankstein, Ron, Rivera, Juan J., Agatston, Arthur, O’Leary, Daniel H., Lima, Joao, Blumenthal, Roger S., Nasir, Khurram
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3173039/
https://ncbi.nlm.nih.gov/pubmed/21856482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(11)60784-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars